TME, known as an important prognostic marker in cancer patients [18,41], features with various pro-inflammatory cytokines including tumor necrosis factor-α (TNF-α), IL-1β and IL-6 to build a tumor-supportive microenvironment to escape immune surveillance [18,41,42]. The gene discussed is IL6; the disease is cancer.